10.1016/S0002-9394(01)01365-4
Synthesis of ROS-sensitive polymers (P1) To a solution of 1 h,1 h,10 h,10h-perfluoro-1,10-decanediol (0.62 g, 1.35 mmol) and ROS sensitive molecular (2,2-(propane-2,2-diylbis(sulfanediyl))bis(ehan-1-ol)) (0.26 g, 1.35 mmol) in anhydrous DMF (5 mL), 1,2,4,5-cyclohexanetetracarboxylic dianhydride (0.63 g, 2.83 mmol) was quickly added
This association was especially notable among younger patients without proteinuria and those not receiving sulfonylurea, dipeptidyl peptidase-4 inhibitors, or RAAS blockers
Cardoso P, Young KG, Nair ATN et al (2024) Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Phase 2 MARITIME data showed 20.0% body weight reduction at 420mg monthly dose over 52 weeks , matching weekly semaglutide and tirzepatide efficacy from a once-monthly format
Can men use glutathione and glycolic acid